期刊文献+

CASP8、Fas基因多态性与汉族非霍奇金淋巴瘤患者预后的关系 被引量:1

Relationships between CASP8,Fas Gene Polymorphisms and the Prognosis of Patients with Non-Hodgkin’s Lymphoma in Han Nationality
下载PDF
导出
摘要 目的:探讨胱天蛋白酶8(CASP8)、脂肪酸合成酶(Fas)基因多态性与汉族非霍奇金淋巴瘤患者预后的关系。方法:回顾性分析85例汉族非霍奇金淋巴瘤患者的临床资料,检测CASP8、Fas基因多态性,统计预后情况,对比不同预后患者CASP8、Fas基因多态性,探讨基因多态性与患者预后不良的关系。结果:本组85例患者预后不良发生率为65.88%;预后不良与预后良好患者CASP8、Fas基因多态性均符合Hardy-Weinberg遗传平衡定律;预后不良患者CASP8基因rs 1035142位点GG基因型频率、等位基因G频率,Fas基因rs 1377位点GA基因型频率、等位基因A频率均明显低于预后良好患者(P<0.05),CASP8基因rs 1035142位点GT、TT基因型频率、等位基因T频率,Fas基因rs 1377位点GG基因型频率和等位基因G频率均明显高于预后良好患者(P<0.05);预后不良患者Ann Arbor分期Ⅲ-Ⅳ期、高度恶性占比均明显高于预后良好患者(P<0.05);Logistic多元回归分析显示,Ann Arbor分期Ⅲ-Ⅳ期、中度恶性、高度恶性、CASP8 rs 1035142 GT基因型、CASP8 rs 1035142 TT基因型、Fas rs 1377 GG基因型均为患者预后不良的危险因素(P<0.05)。结论:汉族非霍奇金淋巴瘤患者预后不良发生率较高,Ann Arbor分期Ⅲ-Ⅳ期、中高度恶性、CASP8 rs 1035142 GT基因型、CASP8 rs 1035142 TT基因型、Fas rs 1377 GG基因型均是其预后不良的危险因素。 Objective:To investigate the relationships between caspase-8(CASP8),fatty acid synthetase(Fas)gene polymorphisms and prognosis of non-Hodgkin’s lymphoma patients in Han nationality.Methods:The clinical data of85 patients with non-Hodgkin’s lymphoma were analyzed retrospectively.The polymorphisms of CA SP8 and Fas gene were detected,and prognosis of the patients were analyzed.The polymorphisms of CASP8 and Fas gene in patients with different prognosis were compared,and the relationships between gene polymorphisms and the poor prognosis of the patients were investigated.Results:The incidence rate of poor prognosis of the patients enrolled in the study was65.88%.The polymorphisms of CA SP8 and Fas genes in the patients with poor or good prognosis were in accordance with Hardy Weinberg’s law of genetic balance.The frequencies of GG genotype and G allele at rs 1035142 of CA SP8 gene,GA genotype and A allele at rs 1377 of Fas gene in patients with poor prognosis were lower than those of the patients with good prognosis(P<0.05).The frequencies of GT,TT and T alleles at rs 1035142 of CASP8 gene,GG and G alleles at rs 1377 of Fas gene in patients with poor prognosis were higher than those of the patients with good prognosis(P<0.05).The proportions of Ann Arbor stageⅢ-Ⅳand high malignancy in patients with poor prognosis were higher than those of the patients with good prognosis(P<0.05).Logistic multiple regression analysis showed that Ann Arbor stageⅢ-Ⅳ,moderate malignant,high malignancy,CASP8 rs 1035142 GT genotype,CASP8 rs 1035142 TT genotype and Fas rs 1377 GG genotype were all the risk factors for the poor prognosis of the patients(P<0.05).Conclusion:The poor prognosis rate of non-Hodgkin’s lymphoma patients in Han nationality is relatively high,and the risk factors for the prognosis of the patients include Ann Arbor stageⅢ-Ⅳ,moderate and high malignancy,CA SP8 rs 1035142 GT genotype,CASP8 rs 1035142 TT genotype and Fas rs 1377 GG genotype.
作者 黄燕 胡苏 崔文婷 HUANG Yan;HU Su;CUI Wen-Ting(Department of Hematology,Jiujiang NO.1 Peopled Hospital,Jiujiang 332000,Jiangxi Province,China)
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2021年第5期1493-1497,共5页 Journal of Experimental Hematology
关键词 胱天蛋白酶8 脂肪酸合成酶 基因多态性 非霍奇金淋巴瘤 预后 caspase-8 fatty acid synthetase gene polymorphism non Hodgkin′s lymphoma prognosis J Exp Hematol 51493-1
  • 相关文献

参考文献7

二级参考文献34

  • 1Angelo Zullo,Cesare Hassan,Francesca Cristofari,Francesco Perri,Sergio Morini.Gastric low-grade mucosal-associated lymphoid tissue-lymphoma: Helicobacter pylori and beyond[J].World Journal of Gastrointestinal Oncology,2010,2(4):181-186. 被引量:21
  • 2杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1479
  • 3周立强,孙燕,谭文勇,李陶,王琦路,冯凤仪,王金万,储大同,石远凯,李晔雄,孙云田,吕宁.非霍奇金淋巴瘤1125例临床病理分析[J].癌症进展,2006,4(5):391-397. 被引量:47
  • 4Morrison VA.Evolution of R-CHOP therapy for older patients with diffuse large B-cell lymphoma.Exp Rev Anticancer Ther,2008,8:1651-1658.
  • 5Thieblemont C,Grossoeuvre A,Houot R,et al.Non-Hodgkin' s lymphoma in very elderly patients over 80 years.A descriptive analysis of clinical presentation and outcome.Ann Oncol,2008,19:774-779.
  • 6Hoerni B,Sotto JJ,Eghbali H,et al.Non-Hodgkin's malignant lymphomas in patients older than 80:70 cases.Cancer,1988,61:2057 -2059.
  • 7Kim DH,Baek JH,Chae YS,et al.Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large Bcell lymphoma.Leukemia,2007,21:2227-2230.
  • 8Weisenburger DD.Epidemiology of non-Hodgkin' s lymphoma:recent findings regarding an emerging epidemic.Ann Oncol,1994,5Suppl 1:19-24.
  • 9Balducci L,Extermann M.Cancer and aging.An evolving panorama.Hematol Oncol Clin North Am,2000,14:1-16.
  • 10Bairey O,Benjamini O,Blickstein D,et al.Non-Hodgkin' s lymphoma in patients 80 years of age or older.Ann Oncol,2006,17:928-934.

共引文献63

同被引文献14

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部